Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (12)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Hanemann, C. O.
Right arrow Articles by Müller, H. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hanemann, C. O.
Right arrow Articles by Müller, H. W.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol. 123, No. 5, 1001-1006, May 2000
© 2000 Oxford University Press

Mutation-dependent alteration in cellular distribution of peripheral myelin protein 22 in nerve biopsies from Charcot–Marie–Tooth type 1A

.

C. Oliver Hanemann1, Donatella D'Urso1,*, Anneke A. W. M. Gabreëls-Festen2 and Hans W. Müller1

1 Molecular Neurobiology Laboratory, Department of Neurology, Heinrich-Heine-University, Duesseldorf, Germany and 2 Institute of Neurology, University Hospital Nijmegen, Nijmegen, Netherlands

Correspondence to: C. O. Hanemann, MD, Neurology ZKF, Universität Ulm, Helmholzstrasse 8/1, 89081 Ulm, Germany E-mail: oliver.hanemann{at}medizin.uni-ulm.de

The hereditary demyelinating neuropathy Charcot–Marie–Tooth type 1A is caused by duplication or by point mutations of the PMP22 gene. Histopathological differences in these genotypes suggest distinct disease mechanisms. In the present investigation we demonstrate a pathologically altered cellular distribution of PMP22 in sural nerve biopsies of patients with PMP22 point mutations. In these patients, in contrast to findings in patients with PMP22 duplication, PMP22 partially accumulates in the Schwann cells instead of being inserted in the myelin sheath. These findings may explain the different histopathology and may suggest different mechanisms of pathogenesis in these genotypes.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Neurosci.Home page
J. Fortun, W. A. Dunn Jr, S. Joy, J. Li, and L. Notterpek
Emerging Role for Autophagy in the Removal of Aggresomes in Schwann Cells
J. Neurosci., November 19, 2003; 23(33): 10672 - 10680.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
N. Sambuughin, A. de Bantel, S. McWilliams, and K. Sivakumar
Deafness and CMT disease associated with a novel four amino acid deletion in the PMP22 gene
Neurology, February 11, 2003; 60(3): 506 - 508.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. R. Tobler, N. Liu, L. Mueller, and E. M. Shooter
Differential aggregation of the Trembler and Trembler J mutants of peripheral myelin protein 22
PNAS, January 8, 2002; 99(1): 483 - 488.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.